| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ayala Pharmaceuticals, Inc. (ADXS) has 0 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. ADXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2015 | Adage Capital Partners GP LLC64 | 10% Owner | Buy | 500,000 | $19.00 | $9,500,000.00 | +9.7% | |
| Feb 18, 2015 | Adage Capital Partners GP LLC64 | 10% Owner | Buy | 684,762 | $7.50 | $5,135,715.00 | +15.4% |